Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases

OBJECTIVE: Brain metastases occur in one-third of all non-small-cell lung cancer patients. Due to restrictive transport at the blood–brain barrier, many drugs provide poor control of metastases in the brain. The aim of this study was to compare erlotinib with pemetrexed as second-/third-line treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yayi, Sun, Wenwen, Wang, Yan, Ren, Shengxiang, Li, Xuefei, Li, Jiayu, Rivard, Christopher J, Zhou, Caicun, Hirsch, Fred R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844452/
https://www.ncbi.nlm.nih.gov/pubmed/27143936
http://dx.doi.org/10.2147/OTT.S102236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844452/
https://www.ncbi.nlm.nih.gov/pubmed/27143936
http://dx.doi.org/10.2147/OTT.S102236

Ejemplares similares